Form D — GT Biopharma, Inc.
0000109657-26-000001 · filed Sep 29, 2026
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $38,958,054
- Total sold
- $7,750,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- GT Biopharma, Inc.
- CIK
- 109657
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 505 MONTGOMERY STREET
SAN FRANCISCO, CA 94111 - Phone
- (415) 919-4040
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Michael Breen · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Alan Urban · Executive OfficerSAN FRANCISCO, CA Find on LinkedIn ↗
-
Charles J. Casamento · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
Hilary Kramer · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
-
David C. Mun-Gavin · DirectorSAN FRANCISCO, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗